1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA SPECC1L CTRPv2 pan-cancer AAC -0.12 0.0005
mRNA TMBIM1 CTRPv2 pan-cancer AAC 0.14 0.0005
mRNA B3GNT9 CTRPv2 pan-cancer AAC -0.14 0.0005
mRNA CUL7 CTRPv2 pan-cancer AAC -0.12 0.0005
mRNA ACAA1 CTRPv2 pan-cancer AAC 0.13 0.0005
mRNA HECW2 CTRPv2 pan-cancer AAC -0.12 0.0005
mRNA STC2 CTRPv2 pan-cancer AAC -0.12 0.0005
mRNA NDRG1 CTRPv2 pan-cancer AAC 0.12 0.0005
mRNA CYBB CTRPv2 pan-cancer AAC 0.13 0.0005
mRNA CCDC88A CTRPv2 pan-cancer AAC -0.14 0.0005
Download CSV